XT
INMB icon

XTX Topco’s INmune Bio INMB Stock Holding History

XTX Topco’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8K Buy
35,461
+5,155
+17% +$7.13K ﹤0.01% 3683
2026
Q1 		$34.2K Sell
30,306
-38,559
-56% -$54.9K ﹤0.01% 3419
2025
Q4 		$107K Buy
68,865
+20,121
+41% +$35.9K ﹤0.01% 2618
2025
Q3 		$101K Sell
48,744
-77,103
-61% -$176K 0.01% 2022
2025
Q2 		$291K Buy
125,847
+88,928
+241% +$653K 0.01% 1457
2025
Q1 		$288K Sell
36,919
-24,352
-40% -$193K 0.01% 1439
2024
Q4 		$286K Buy
61,271
+15,018
+32% +$78.3K 0.02% 1262
2024
Q3 		$249K Buy
+46,253
New +$329K 0.02% 1312

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco's INMB Position: Q2 2026 in Review

XTX Topco increased its INmune Bio (INMB) stake by 17% in Q2 2026, buying an estimated $7.13K and bringing the position to 35,461 shares worth $57.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

XTX Topco first reported a position in INMB in Q3 2024 and has held it in 8 quarters since. The position peaked at $291K in Q2 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • XTX Topco held 35,461 shares of INmune Bio worth $57.8K as of Q2 2026.
  • XTX Topco bought 5,155 INmune Bio shares in Q2 2026, an estimated $7.13K.
  • INmune Bio made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3683 holding.
  • XTX Topco first reported a position in INmune Bio in Q3 2024 and has held it in 8 quarters since.
  • XTX Topco's INmune Bio position peaked at $291K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.